SPHK1 and pulmonary arterial hypertension: SphK1 was shown to be upregulated in patients with pulmonary arterial hypertension (PAH) and its genetic deletion and pharmacologic inhibition protected against the development of hypoxia-mediated pulmonary hypertension (HPH) in mice (doi: 10.1164/rccm.201401-0121OC).